Alexion Pharmaceuticals Investor Relations Material
Latest events
Q4 2020
8 Feb, 2021
Q4 2019
4 Feb, 2020
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Alexion Pharmaceuticals Inc
Access all reports
Alexion Pharmaceuticals Inc focused on the development and commercialization of therapies for rare diseases. The company specialized in biologics targeting immune-mediated rare conditions and offered treatments across neurology, hematology, nephrology, and metabolic disorders. Alexion operated globally through research, manufacturing, and commercial networks. The company was headquartered in Boston, Massachusetts, and its shares were listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ALXN
Country
🇺🇸 United States